Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab
NCT00287378
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
lack of enrollment
Conditions
Asthma
Allergy
Interventions
DRUG:
omalizumab
Sponsor
University of North Carolina, Chapel Hill
Collaborators
[object Object]
[object Object]